Evidence map›Paper›PMID 29569624›Full record

ReviewNature reviews. Neurology2018

Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Rebekah M Ahmed, Yazi D Ke, Steve Vucic, Lars M Ittner, William Seeley, John R Hodges, Olivier Piguet, Glenda Halliday, Matthew C Kiernan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Potential Roles of Neuroimaging in Motor Neuron Disease.Current neurology and neuroscience reports · 2026
    Review
  5. Article
  6. Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Terpenoid natural products exert neuroprotectionFrontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rebekah M AhmedBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Yazi D KeDementia Research Unit, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
Steve VucicBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Lars M IttnerDementia Research Unit, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
William SeeleyDepartment of Neurology and Department of Pathology, University of California San Francisco Memory and Aging Center, San Francisco, CA, USA.
John R HodgesBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Olivier PiguetAustralian Research Council Centre of Excellence in Cognition and its Disorders, Sydney, Australia.
Glenda HallidayBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Matthew C KiernanBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
University of Sydney · AUUNSW Sydney · AUAustralian Research Council · AURoyal Prince Alfred Hospital · AUUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of neurodegenerative syndromes extend beyond cognitive function to involve key physiological processes, including eating and metabolism, autonomic nervous system function, sleep, and motor function. Changes in these physiological processes are present in several conditions, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer disease and the parkinsonian plus conditions. Key neural structures that mediate physiological changes across these conditions include neuroendocrine and hypothalamic pathways, reward pathways, motor systems and the autonomic nervous system. In this Review, we highlight the key changes in physiological processing in neurodegenerative syndromes and the similarities in these changes between different progressive neurodegenerative brain conditions. The changes and similarities between disorders might provide novel insights into the human neural correlates of physiological functioning. Given the evidence that physiological changes can arise early in the neurodegenerative process, these changes could provide biomarkers to aid in the early diagnosis of neurodegenerative diseases and in treatment trials.

Indexed as

Alzheimer DiseaseAmyotrophic Lateral SclerosisAutonomic Nervous SystemFrontotemporal DementiaHypothalamusNerve NetParkinsonian DisordersSleep Wake DisordersAnimalsHumans

Identifiers

PMID29569624
OpenAlexW2794076331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.